Transgenic zebrafish model of DUX4 misexpression reveals a developmental role in FSHD pathogenesis
Anna Pakuła(Boston Children's Hospital), Louis M. Kunkel(Boston Children's Hospital), Vandana Gupta(Brigham and Women's Hospital), Jeffrey J. Widrick(University of Massachusetts Chan Medical School), Fedik Rahimov(AbbVie (United States)), Tracy Zhang(Boston Children's Hospital), Angela Lek(Muscular Dystrophy Association), June Criscione(Boston Children's Hospital), Lillian Mead(Boston Children's Hospital), Katlynn Bugda Gwilt(Brigham and Women's Hospital), Hiroaki Mitsuhashi(National Center of Neurology and Psychiatry), Anusha Manglik(Boston Children's Hospital), Quinn Murphy(Boston Children's Hospital), Devin Gibbs(Boston Children's Hospital)
Cited by 22
Related Papers
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
|PubMed|1989|961
Disruption of an AP-2α binding site in an IRF6 enhancer is associated with cleft lip
|Nature Genetics|2008|427
Life-long sustained mortality advantage of siblings of centenarians
|Proceedings of the National Academy of Sciences|2002|374
A genome-wide scan for linkage to human exceptional longevity identifies a locus on chromosome 4
|Proceedings of the National Academy of Sciences|2001|351
Death after High-Dose rAAV9 Gene Therapy in a Patient with Duchenne’s Muscular Dystrophy
|New England Journal of Medicine|2023|302